PEOPLE ON THE MOVE
Astellas
Astellas Pharma Europea, the EMEA business of Tokyo-based pharma Astellas Pharma, has promoted Eugene Van Rensburg as Chief Financial Officer from his previous role as Senior Finance Director.
Van Rensburg succeeds Niek Stander, who will head up the company's German operations as Managing Director of Astellas Pharma GmbH.
Astellas was founded in 2005 through the merger of Yamanouchi and Fujisawa. The EMEA region contributes about a quarter of the Japanese company’s global sales; Astellas reported €2.3bn in EMEA sales in FY2014.
As CFO Van Rensburg will oversee finances in 40 European, Middle Eastern and African countries. He commented, "It is an exciting time to be a trusted advisor and part of the leadership team at Astellas. Our company is building on existing areas of excellence, such as our franchises in urology, oncology and transplantation, by proactively seeking novel technologies and new opportunities in different therapeutic areas. We've recently launched three new classes of treatment in the EMEA region, and with eight therapies in late stage development, Astellas has a unique platform for continued growth."